Lacosamide oral

DRUG2 trials

Sponsors

UCB Pharma SA, UCB Biopharma SRL

Conditions

Electroencephalographic Neonatal SeizuresEpilepsyHealthy Volunteers

Phase 1

Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects

CompletedNCT01986608

UCB Pharma SAHealthy Volunteers

Start: 2013-11-30End: 2013-12-31Updated: 2014-09-12

Phase 2

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

TerminatedNCT04519645

UCB Biopharma SRLElectroencephalographic Neonatal Seizures, Epilepsy

Start: 2021-03-31End: 2024-10-31Updated: 2025-10-03